Skip to main content

Table 2 Comparison of patient clinical characteristics with TMTV

From: Prognostic value of baseline total metabolic tumour volume of 18F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma

Characteristics No. of patients (n = 56) TMTV
Low (n = 29) High (n = 27) P value
Sex, female/male 23/33 16/13 7/20 0.026
Age, ≤ 60/ > 60 20/36 13/16 7/20 0.140
B symptoms, no/yes 20/36 12/17 8/19 0.359
LDH, normal/elevated 14/42 10/19 4/23 0.089
ECOG-PS,0–1/2–5 43/13 27/2 16/11 0.003
PLT count, normal/declined 35/21 22/7 13/14 0.032
Albumin, normal/declined 15/41 9/20 6/21 0.457
β2-MG, normal/elevated 20/36 11/18 9/18 0.720
BMB, negative/positive 43/13 25/4 18/9 0.084
Ann Arbor stage II–III/IV 28/28 21/8 7/20 0.001
Extranodal sites > 1, no/yes 47/9 26/3 21/6 0.227
IPI,0–2/3–5 25/31 13/16 12/15 0.977
PIT,0–1/2–4 36/20 23/6 13/14 0.015
  1. LDH, lactate dehydrogenase; ECOG-PS, Eastern Cooperative Oncology Group Performance Status; PLT, platelet; β2-MG, β2-microglobulin; BMB, bone marrow biopsy; IPI, international prognostic index; PIT, prognostic index for T-cell lymphoma